Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Japan
  4. Japan Exchange
  5. Astellas Pharma Inc.
  6. News
  7. Summary
    4503   JP3942400007

ASTELLAS PHARMA INC.

(4503)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about ASTELLAS PHARMA INC.
06/17ASTELLAS PHARMA  : Notice Regarding Impairment Loss Following the Termination of..
PU
06/16ASTELLAS PHARMA  : Transfers Five Legacy Products in Europe, Russia, CIS and Asi..
PU
06/09ASTELLAS PHARMA  : New Research Reflects Astellas' Commitment to Acute Myeloid L..
AQ
06/02ASTELLAS PHARMA  : Reviewing capabilities for sustainable growth - Astellas Will..
PU
05/26Japanese shares fall on profit-taking, pandemic worries
RE
05/20ASTELLAS PHARMA  : and Seagen Announce Updated Results from Two Trials of PADCEV..
AQ
05/19ASTELLAS PHARMA  : Seagen and Astellas Announce Updated Results from Two Trials ..
BU
05/18Astellas to Present Data from Expanding Oncology Portfolio During the 2021 AS..
AQ
05/12ASTELLAS PHARMA  : Notice Regarding Continuation of the Performance-linked Stock..
PU
05/06ASTELLAS PHARMA  : ' XTANDI (enzalutamide) Approved by European Commission for M..
PU
05/05ASTELLAS PHARMA  : ' XTANDI (enzalutamide) Approved by European Commission for M..
AQ
04/28ASTELLAS PHARMA INC.  : - Notice Regarding Impairment Loss for Investigational G..
AQ
04/28ASTELLAS PHARMA INC.  : - Change of Directors
AQ
04/27ASTELLAS PHARMA  : Change of Directors
PU
04/26ASTELLAS PHARMA  : Notice Regarding Impairment Loss for Investigational Gene The..
PU
More most relevant news
All news about ASTELLAS PHARMA INC.
06/17ASTELLAS PHARMA  : Notice Regarding Impairment Loss Following the Termination of..
PU
06/16ASTELLAS PHARMA  : Transfers Five Legacy Products in Europe, Russia, CIS and Asi..
PU
06/09ASTELLAS PHARMA  : New Research Reflects Astellas' Commitment to Acute Myeloid L..
AQ
06/08Heavyweights pull Nikkei lower, Topix gains on drugmakers' boost
RE
06/07Nikkei falls as market heavyweights offset gains in drugmakers
RE
06/02ASTELLAS PHARMA  : Reviewing capabilities for sustainable growth - Astellas Will..
PU
06/02PRESS RELEASE : MorphoSys to Acquire Constellation -2-
DJ
05/31Japanese shares end lower on profit-booking, drugmakers limit losses
RE
05/30Japanese shares retreat from 3-week high; drugmakers limit losses
RE
05/26Japanese shares fall on profit-taking, pandemic worries
RE
More news
News in other languages on ASTELLAS PHARMA INC.
06/02Morphosys schluckt US-Krebsspezialisten - Aktie bricht ein
06/02ADOCIA  : trois nominations et une démission au conseil
06/02DGAP-NEWS : MorphoSys übernimmt Constellation -2-
06/02DGAP-ADHOC : MorphoSys AG übernimmt Constellation -2-
05/31TOKYO STOCK EXCHANGE : Borsa Tokyo chiude in ribasso su prese di profitto, bene ..
04/27MÄRKTE ASIEN/Wenig Bewegung - Musik spielt bei Einzelwerten
04/27DGAP-NEWS : MIG AG verzeichnet 2020 bestes Jahr der Unternehmensgeschichte und s..
03/18TOKYO STOCK EXCHANGE : Borsa Tokyo in rialzo su previsioni crescita Fed, Topix a..
03/02ASTRAZENECA  : la FDA va se pencher sur le roxadustat
03/01ANTIRION  : nuova sede a Milano per Astellas Pharma
More news
Press releases
06/17ASTELLAS PHARMA  : Notice Regarding Impairment Loss Following the Termination of..
PU
06/16ASTELLAS PHARMA  : Transfers Five Legacy Products in Europe, Russia, CIS and Asi..
PU
06/09ASTELLAS PHARMA  : New Research Reflects Astellas' Commitment to Acute Myeloid L..
AQ
06/02ASTELLAS PHARMA  : Reviewing capabilities for sustainable growth - Astellas Will..
PU
05/20ASTELLAS PHARMA  : and Seagen Announce Updated Results from Two Trials of PADCEV..
AQ
More press releases
Upcoming event on ASTELLAS PHARMA INC.